Montrose Environmental Group Reports Record Third Quarter and First Nine Months 2024 Results, Reaffirms Guidance, and Updates Strategic Capital Allocation Priorities

Third Quarter 2024 Highlights (comparisons to third quarter 2023)

    --  Highest-ever total revenue of $178.7 million, an increase of $10.8
        million, or 6.4%
    --  Net loss of $10.6 million, or $0.39 net loss per diluted share
        attributable to common stockholders (LPS), and Adjusted Net Income(1) of
        $19.1 million, or $0.41 Diluted Adjusted Net Income per share(1) (Adj
        EPS)
    --  Record Consolidated Adjusted EBITDA(1) of $28.3 million, an increase of
        $5.0 million, or 21.5%
    --  Consolidated margin expansion
    --  Reaffirms full-year 2024 guidance for total revenue of $690 million to
        $740 million, and Consolidated Adjusted EBITDA(1) of $95 million to $100
        million

First Nine Months 2024 Highlights (comparisons to first nine months 2023)

    --  Record total revenue of $507.4 million, an increase of $48.9 million, or
        10.7%
    --  Net loss of $34.1 million, or $1.30 LPS, and Adjusted Net Income(1) of
        $38.6 million, or $0.80 Adj EPS(1)
    --  Record Consolidated Adjusted EBITDA(1) of $68.5 million, an increase of
        $7.5 million, or 12.2%
    --  Received five patents in 2024, bringing total patent portfolio to 23,
        which enhance differentiated capabilities across multiple contaminants,
        including PFAS

Strategic Capital Allocation Priorities

    --  Long-term capital allocation strategy unchanged
    --  Near-term priority is redemption of preferred equity and subsequent
        deleveraging; concurrently de-emphasizing acquisitions
    --  Continued focus on cash flow generation

LITTLE ROCK, Ark., Nov. 6, 2024 /PRNewswire/ -- Montrose Environmental Group, Inc. (the "Company," "Montrose" or "MEG") (NYSE: MEG) today announced results for the third quarter and first nine month periods ended September 30, 2024.

Montrose Chief Executive Officer and Director, Vijay Manthripragada, commented, "We are pleased to report another quarter of strong performance with record results driven by continued demand for our comprehensive suite of integrated solutions. Record quarterly revenues and Consolidated Adjusted EBITDA(1), as well as the 190 basis points of margin improvement, evidence the alignment of our in-demand, higher-margin offerings with our strategic and financial goals. Our strong track record of organic growth, including ongoing cross-selling success, alongside the successful integration of recent acquisitions, continue to demonstrate the strategic advantages provided by our business model."

Mr. Manthripragada continued, "Our long-term capital allocation strategy is unchanged. In the near-term, we will prioritize redemption of the preferred equity and subsequent deleveraging. This provides an opportunity for the underlying organic growth potential of our business to shine. And, we remain steadfast in our commitment to strong cash flow generation. We believe these combined efforts will demonstrate to our employees, clients, colleagues and shareholders the true value creation afforded by our Company."

"As we look ahead, we remain confident in our growth trajectory, supported by overall favorable regulatory tailwinds and resilient client demand. The increasing complexity of environmental regulations, coupled with escalating private sector commitments to environmental stewardship, continue to drive demand for our integrated services across our operations in North America, Australia, and Europe."



     _______________________________



     (1)                             Consolidated Adjusted EBITDA, Adjusted Net Income (Loss) and Adjusted Net Income (Loss) per Share are non-GAAP measures. See the appendix to this release for a discussion of these measures, including how they are calculated and the reasons why we believe they provide useful information to investors, and a
                                        reconciliation for historical periods to the most directly comparable GAAP measures.

Third Quarter 2024 Results

Total revenue in the third quarter of 2024 was $178.7 million compared to $167.9 million in the prior year quarter, an increase of 6.4%. The increase in revenue was primarily comprised of strong organic growth in our Assessment, Permitting and Response and Measurement and Analysis segments, and $15.4 million from acquisitions, partially offset by a $12.8 million reduction in environmental emergency response revenue and lower treatment technology revenue.

Net loss was $10.6 million, or $0.39 of LPS, in the third quarter of 2024, compared to net loss of $7.5 million, or $0.39 LPS, in the prior year quarter. The year-over-year change in net loss was primarily attributable to higher interest in the current year quarter, partially offset by improved loss from operations. The flat comparative period LPS was due to lower dividends on our Series A-2 Preferred Stock (Series A-2) and a higher weighted average outstanding share count, partially offset by a Net loss increase.

In the third quarter of 2024, Adjusted Net Income(1) and Adj EPS(1 )were $19.1 million and $0.41, respectively, increases compared to the prior year quarter Adjusted Net Income(1) and Adj EPS(1) of $15.7 million and $0.31, respectively. Adjusted Net Income(1) in the current year period was higher than the prior year period primarily resulting from the improvement in operating income before amortization expense and acquisition costs, partially offset by higher interest expense. In the current year period, Adj EPS(1) was higher than the prior year period primarily due to the increase in Adjusted Net Income and the lower dividends on our Series A-2, partially offset by a higher weighted average outstanding share count in the quarter.

Third quarter 2024 Consolidated Adjusted EBITDA(1 )was $28.3 million, or 15.8% of revenue, compared to $23.3 million, or 13.9% of revenue, in the prior year quarter. The increase in Consolidated Adjusted EBITDA(1) was due to higher revenue driven by organic growth and acquisitions. The increase in Consolidated Adjusted EBITDA(1) as a percentage of revenue resulted primarily from organic growth, the benefits from recent acquisitions, and lower corporate expenses, partially timing related.

First Nine Months 2024 Results

Total revenue in the first nine months of 2024 increased 10.7% to $507.4 million compared to $458.5 million in the prior year period. The increase in revenue was primarily comprised of strong organic growth in our Measurement and Analysis and Assessment, Permitting and Response segments, and $63.6 million from acquisitions, partially offset by a $34.9 million reduction in environmental emergency response revenue and lower treatment technology revenue.

Net loss was $34.1 million, or $1.30 LPS, in the first nine months of 2024 compared to a net loss of $29.4 million, or $1.39 LPS, in the prior year period. The year-over-year increase in net loss was primarily attributable to higher interest and income tax expenses in the current year period, partially offset by an improved loss from operations. Improved LPS was a result of lower dividends on the Series A-2 and a higher weighted average outstanding share count, partially offset by a higher net loss.

In the first nine months of 2024, Adjusted Net Income(1) and Adj EPS were $38.6 million and $0.80, respectively, compared to prior year period Adjusted Net Income(1) and Adj EPS(1) of $40.9 million and $0.78, respectively. Adjusted Net Income(1) in the current year period was lower than the prior year period primarily resulting from increases in interest and income tax expenses, partially offset by the improved operating loss. In the current year period, Adj EPS(1) was higher than the prior year period primarily from the lower dividends on our Series A-2, partially offset by lower Adjusted Net Income(1) and a higher weighted average outstanding share count in the year-to-date period.

Consolidated Adjusted EBITDA(1) for the first nine months of 2024 was $68.5 million, or 13.5% of revenues, compared to $61.1 million, or 13.3% of revenues, in the prior year period. The increase in Consolidated Adjusted EBITDA(1) was primarily due to higher revenues driven by organic growth and acquisitions.

Operating Cash Flow, Liquidity and Capital Resources

Cash used in operating activities for the first nine months ended September 30, 2024, was $9.7 million compared to cash provided by operating activities of $41.5 million in the prior year period. The year-over-year decrease was primarily due to an increase in accounts receivable and contract assets associated with higher revenues. The previously discussed temporary invoicing delays associated with the integration of Matrix are substantially addressed and collections are returning to a normal cadence. In addition, slower payments on a single, large, U.S. government funded project are expected to be resolved by year end. Excluding the impact of Matrix and the U.S. government funded project, days sales outstanding were unchanged compared to the prior year period.

As of September 30, 2024, Montrose had $139.8 million of liquidity, including $13.0 million of cash and $126.7 million of availability on its revolving credit facility.

As of September 30, 2024, Montrose's leverage ratio under its credit facility, which includes the impact of recently completed acquisitions of Spirit Environmental and Origins Laboratory, was 2.6x.

Recent Acquisitions

In July 2024, Montrose acquired Spirit Environmental, LLC. ("Spirit"), a leading environmental consultant specializing in air permitting and compliance services across the central U.S. Spirit is included within the Company's Assessment, Permitting & Response segment.

In September 2024, Montrose acquired substantially all the assets of Origins Laboratory, Inc. ("Origins"), an accredited environmental analytical testing laboratory. Origins is included within the Company's Measurement and Analysis segment.

Full Year 2024 Outlook

The Company reaffirms its full year 2024 Revenue and Consolidated Adjusted EBITDA(1 )outlook. The Company expects Revenue to be in the range of $690 million to $740 million. Consolidated Adjusted EBITDA(1 )is expected to be in the range of $95 million to $100 million for the full year 2024.

Our Revenue and Consolidated Adjusted EBITDA(1 )outlook does not include any benefit from future acquisitions.

Webcast and Conference Call

The Company will host a webcast and conference call on Thursday, November 7, 2024, at 8:30 a.m. Eastern time to discuss third quarter financial results. The prepared remarks will be followed by a question-and-answer session. A live webcast of the conference call will be available in the Investors section of the Montrose website at www.montrose-env.com. The conference call will also be accessible by dialing 1-844-826-3035 (Domestic) and 1-412-317-5195 (International). For those who are unable to listen to the live broadcast, an audio replay of the conference call will be available on the Montrose website for 30 days.

About Montrose

Montrose is a leading environmental solutions company focused on supporting commercial and government organizations as they deal with the challenges of today and prepare for what's coming tomorrow. With ~3,400 employees across 100+ locations worldwide, Montrose combines deep local knowledge with an integrated approach to design, engineering, and operations, enabling Montrose to respond effectively and efficiently to the unique requirements of each project. From comprehensive air measurement and laboratory services to regulatory compliance, environmental emergency response, permitting, engineering, and remediation, Montrose delivers innovative and practical solutions that keep its clients on top of their immediate needs - and well ahead of the strategic curve. For more information, visit www.montrose-env.com.

Forward?Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as "intend," "expect", and "may", and other similar expressions that predict or indicate future events or that are not statements of historical matters. Forward-looking statements are based on current information available at the time the statements are made and on management's reasonable belief or expectations with respect to future events, and are subject to risks and uncertainties, many of which are beyond the Company's control, that could cause actual performance or results to differ materially from the belief or expectations expressed in or suggested by the forward-looking statements. Additional factors or events that could cause actual results to differ may also emerge from time to time, and it is not possible for the Company to predict all of them. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect future events, developments or otherwise, except as may be required by applicable law. Investors are referred to the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2023, for additional information regarding the risks and uncertainties that may cause actual results to differ materially from those expressed in any forward-looking statement.

Contact Information:

Investor Relations:
Adrianne D. Griffin
(949) 988-3383
ir@montrose-env.com

Media Relations:
Sarah Kaiser
(225) 955-1702
pr@montrose-env.com


                                                                       
          
                MONTROSE ENVIRONMENTAL GROUP, INC.


                                                                   
     
           UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND


                                                                           
              
                COMPREHENSIVE LOSS


                                                                         
             (In thousands, except per share data)




                                                                                                                              Three Months Ended                         Nine Months Ended
                                                                                                                     September 30,                              September 30,


                                                                                                                     2024                         2023                 2024                       2023



              Revenues                                                                                 $
              178,687                 $
         167,937    $
              507,337              $
          458,466



              Cost of revenues (exclusive of depreciation and                                                      105,596                        102,155                306,239                      281,984
    amortization shown below)



              Selling, general and administrative expense                                                           60,869                         56,901                177,182                      161,761



              Fair value changes in business acquisition                                                               143                            459                    385                          414
    contingencies



              Depreciation and amortization                                                                         13,240                         11,863                 37,408                       33,816



              Loss from operations                                                                                 (1,161)                       (3,441)              (13,877)                    (19,509)



              Other income (expense), net                                                                          (3,898)                         (671)               (4,314)                     (1,560)



              Interest expense, net                                                                                (4,137)                       (2,089)              (11,420)                     (5,507)



              Total other income (expense), net                                                                    (8,035)                       (2,760)              (15,734)                     (7,067)



              Loss before expense from income taxes                                                                (9,196)                       (6,201)              (29,611)                    (26,576)



              Income tax expense                                                                                     1,368                          1,324                  4,480                        2,842



              Net loss                                                                                $
              (10,564)                $
         (7,525)  $
              (34,091)            $
          (29,418)





              Equity adjustment from foreign currency translation                                                     (70)                         (198)                  (70)                       (304)



              Comprehensive loss                                                                                  (10,634)                       (7,723)              (34,161)                    (29,722)



              Convertible and redeemable Series A-2 Preferred                                                      (2,750)                       (4,100)               (8,314)                    (12,300)
    Stock dividend



              Net loss attributable to common stockholders                                                        (13,314)                      (11,625)              (42,405)                    (41,718)



                Weighted average common shares outstanding-                                                         34,242                         30,143                 32,647                       30,016
    basic and diluted



              Net loss per share attributable to common                                                 $
              (0.39)                 $
         (0.39)    $
              (1.30)              $
          (1.39)
    stockholders- basic and diluted


                                                                                          
              
                MONTROSE ENVIRONMENTAL GROUP, INC.


                                                                          
              
                UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION


                                                                                                 
              (In thousands, except share data)




                                                                                                                                                                                               September 30,                December 31,


                                                                                                                                                                                            2024                   2023



              
                Assets



              Current assets



              Cash, cash equivalents and restricted cash                                                                                                                             $
        13,045            $
         23,240



              Accounts receivable, net                                                                                                                                                    152,849                  112,360



              Contract assets                                                                                                                                                              65,553                   51,629



              Prepaid and other current assets                                                                                                                                             15,489                   13,695



                         Total current assets                                                                                                                                             246,936                  200,924



              Non-current assets



              Property and equipment, net                                                                                                                                                  66,096                   56,825



              Operating lease right-of-use asset, net                                                                                                                                      40,923                   32,260



              Finance lease right-of-use asset, net                                                                                                                                        17,242                   13,248



              Goodwill                                                                                                                                                                    482,607                  364,449



              Other intangible assets, net                                                                                                                                                144,652                  140,813



              Other assets                                                                                                                                                                  8,437                    8,267



              Total assets                                                                                                                                                        $
        1,006,893           $
         816,786



              
                Liabilities, Convertible and Redeemable Series A-2 Preferred Stock and
    Stockholders' Equity



              Current liabilities



              Accounts payable and other accrued liabilities                                                                                                                         $
        57,579            $
         59,920



              Accrued payroll and benefits                                                                                                                                                 31,556                   34,660



              Business acquisitions contingent consideration, current                                                                                                                       6,423                    3,592



              Current portion of operating lease liabilities                                                                                                                               11,696                    9,963



              Current portion of finance lease liabilities                                                                                                                                  4,232                    3,956



              Current portion of long-term debt                                                                                                                                            16,753                   14,196



                         Total current liabilities                                                                                                                                        128,239                  126,287



              Non-current liabilities



              Business acquisitions contingent consideration, long-term                                                                                                                    27,924                    2,448



              Other non-current liabilities                                                                                                                                                 6,355                    6,569



              Deferred tax liabilities, net                                                                                                                                                 8,274                    6,064



              Conversion option related to Series A-2 Preferred Stock                                                                                                                      20,054                   19,017



              Operating lease liability, net of current portion                                                                                                                            31,543                   25,048



              Finance lease liability, net of current portion                                                                                                                               9,378                    8,185



              Long-term debt, net of deferred financing fees                                                                                                                              233,007                  148,988



                         Total liabilities                                                                                                                                          $
        464,774           $
         342,606



              Commitments and contingencies



              Convertible and redeemable Series A-2 Preferred Stock $0.0001 par value



              Authorized, issued and outstanding shares: 11,667 and 17,500 at September 30,                                                                                                92,928                  152,928
    2024 and December 31, 2023, respectively; aggregate liquidation preference of
                                                                                                          $122.2 million and $182.2 million at September 30, 2024 and December 31,
    2023, respectively



              Stockholders' equity:



              Common stock, $0.000004 par value; authorized shares: 190,000,000 at September
    30, 2024 and December 31, 2023; issued and outstanding shares: 34,296,493
    and 30,190,231 at September 30, 2024 and December 31, 2023, respectively



              Additional paid-in-capital                                                                                                                                                  693,931                  531,831



              Accumulated deficit                                                                                                                                                       (244,447)               (210,356)



              Accumulated other comprehensive (loss) income                                                                                                                                 (293)                   (223)



              Total stockholders' equity                                                                                                                                                  449,191                  321,252



              Total liabilities, convertible and redeemable Series A-2 Preferred Stock and                                                                                        $
        1,006,893           $
         816,786
    Stockholders' Equity


                                                                       
              
                MONTROSE ENVIRONMENTAL GROUP, INC.


                                                            
              
                UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


                                                                                        
              (In thousands)




                                                                                                                                                            For the Nine Months Ended
                                                                                                                                                      September 30,


                                                                                                                                                      2024                             2023



     Operating activities:



     Net loss                                                                                                                                $
        (34,091)                $
            (29,418)



     Adjustments to reconcile net loss to net cash provided by operating activities:



     Depreciation and amortization                                                                                                                   37,408                             33,816



     Amortization of right-of-use asset                                                                                                               8,423                              7,667



     Stock-based compensation expense                                                                                                                34,866                             35,609



     Fair value changes in financial instruments                                                                                                      4,851                              1,814



     Deferred income taxes                                                                                                                            4,931                              2,842



     Other operating activities, net                                                                                                                    315                              2,403



     Changes in operating assets and liabilities, net of acquisitions:



     Accounts receivable and contract assets                                                                                                       (45,898)                           (9,538)



     Accounts payable and other accrued liabilities                                                                                                 (2,192)                             (772)



     Accrued payroll and benefits                                                                                                                   (4,936)                             6,092



     Payment of contingent consideration                                                                                                                                                (611)



     Change in operating leases                                                                                                                     (9,233)                           (7,525)



     Other assets                                                                                                                                   (4,165)                             (907)



     Net cash (used in) provided by operating activities                                                                                            (9,721)                            41,472



     Investing activities:



     Proceeds from corporate owned and property insurance                                                                                               182                                311



     Purchases of property and equipment                                                                                                           (19,086)                          (24,969)



     Proceeds from the sale of property and equipment                                                                                                   401



     Proprietary software development and other software costs                                                                                      (2,052)                           (2,763)



     Purchase price true ups                                                                                                                        (3,413)                           (1,027)



     Minority investments                                                                                                                             (210)                           (2,347)



     Cash paid for acquisitions, net of cash acquired                                                                                             (113,012)                          (66,187)



     Net cash used in investing activities                                                                                                        (137,190)                          (96,982)



     Financing activities:



     Proceeds from line of credit                                                                                                                   326,468



     Repayment of the line of credit                                                                                                              (278,335)



     Proceeds from the aircraft loan                                                                                                                                                   10,935



     Repayment of aircraft loan                                                                                                                       (796)                             (335)



     Proceeds from term loan                                                                                                                         50,000



     Repayment of term loan                                                                                                                        (11,094)                           (8,785)



     Payment of contingent consideration and other purchase price true ups                                                                            (363)                           (1,535)



     Repayment of finance leases                                                                                                                    (4,384)                           (3,378)



     Payments of deferred financing costs                                                                                                             (348)



     Proceeds from issuance of common stock for exercised stock options                                                                               1,973                              4,529



     Proceeds from issuance of common stock in follow-on offering                                                                                   121,776



     Dividend payment to the series A-2 stockholders                                                                                                (8,314)                          (12,300)



     Repayment to the series A-2 stockholders                                                                                                      (60,000)



     Net cash provided by (used in) financing activities                                                                                            136,583                           (10,869)



     Change in cash, cash equivalents and restricted cash                                                                                          (10,328)                          (66,379)



     Foreign exchange impact on cash balance                                                                                                            133                              (265)



     Cash, cash equivalents and restricted cash:



     Beginning of year                                                                                                                               23,240                             89,828



     End of period                                                                                                                             $
        13,045                   $
            23,184


                                        
     
             SEGMENT REVENUES AND ADJUSTED EBITDA


                                              
              (In thousands)


                                               
              (Unaudited)




                                                                 
              
                Three Months Ended September 30,


                                                                                       2024                                                  2023


                                                               Segment                                   Segment                       Segment                 Segment
                                              Revenues                        Adjusted                         Revenues               Adjusted
                                                                              EBITDA(1)                                              EBITDA(1)



            Assessment, Permitting and      $
              52,019                 $
              11,188                  $
         57,009            $
            14,878
    Response



            Measurement and Analysis                    58,583                             13,370                         50,468 (2)                   10,352



            Remediation and Reuse                       68,085                             11,655                         60,460                       7,446



            Total Operating Segments       $
              178,687                 $
              36,213                 $
         167,937            $
            32,676



            Corporate and Other                                                          (7,901)                                                  (9,373)



            Total                          $
              178,687                 $
              28,312                 $
         167,937            $
            23,303




                                                                 
              
                Nine Months Ended September 30,


                                                                                             2024                                          2023


                                                               Segment                                   Segment                       Segment                 Segment
                                              Revenues                        Adjusted                         Revenues               Adjusted
                                                                              EBITDA(1)                                              EBITDA(1)



            Assessment, Permitting and     $
              164,043                 $
              40,088                 $
         170,634            $
            42,977
    Response



            Measurement and Analysis                   158,889                             32,233                        143,050 (2)                   27,528



            Remediation and Reuse                      184,405                             25,594                        144,782                      18,767



            Total Operating Segments       $
              507,337                 $
              97,915                 $
         458,466            $
            89,272



            Corporate and Other                                                         (29,367)                                                 (28,175)



            Total                          $
              507,337                 $
              68,548                 $
         458,466            $
            61,097


     _____________________________________



     (1)                                   For purposes of evaluating segment profit, the Company's chief operating decision maker reviews Segment Adjusted EBITDA as a basis for making the decisions to
                                              allocate resources and assess performance.



     (2)                                   Includes revenue of $2.0 million and $5.9 million from the Discontinued Specialty Lab for the three and nine months ended September 30, 2023, respectively.

Non-GAAP Financial Information

In addition to our results under GAAP, in this release we also present certain other supplemental financial measures of financial performance that are not required by, or presented in accordance with, GAAP, including, Consolidated Adjusted EBITDA, Adjusted Net Income and Basic and Diluted Adjusted Net Income per Share. We calculate Consolidated Adjusted EBITDA as net income (loss) before interest expense, income tax expense (benefit) and depreciation and amortization, adjusted for the impact of certain other items, including stock-based compensation expense and acquisition-related costs, as set forth in greater detail in the table below. We calculate Adjusted Net Income as net income (loss) before amortization of intangible assets, stock-based compensation expense, fair value changes to financial instruments and contingent earnouts, discontinued specialty lab, and other gain or losses, as set forth in greater detail in the table below. Basic and Diluted Adjusted Net Income per Share represents Adjusted Net Income attributable to stockholders divided by the fully diluted number of shares of common stock outstanding during the applicable period.

Consolidated Adjusted EBITDA is one of the primary metrics used by management to evaluate our financial performance and compare it to that of our peers, evaluate the effectiveness of our business strategies, make budgeting and capital allocation decisions and in connection with our executive incentive compensation. Adjusted Net Income and Basic and Diluted Adjusted Net Income per Share are useful metrics to evaluate ongoing business performance after interest and tax. These measures are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe they are helpful in highlighting trends in our operating results because they allow for more consistent comparisons of financial performance between periods by excluding gains and losses that are non-operational in nature or outside the control of management, and, in the case of Consolidated Adjusted EBITDA, by excluding items that may differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments.

These non-GAAP measures do, however, have certain limitations and should not be considered as an alternative to net income (loss), earnings (loss) per share or any other performance measure derived in accordance with GAAP. Our presentation of Consolidated Adjusted EBITDA, Adjusted Net Income and Basic and Diluted Adjusted Net Income per Share should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items for which we may make adjustments. In addition, Consolidated Adjusted EBITDA, Adjusted Net Income and Basic and Diluted Adjusted Net Income per Share may not be comparable to similarly titled measures used by other companies in our industry or across different industries, and other companies may not present these or similar measures. Management compensates for these limitations by using these measures as supplemental financial metrics and in conjunction with our results prepared in accordance with GAAP. We encourage investors and others to review our financial information in its entirety, not to rely on any single measure and to view Consolidated Adjusted EBITDA, Adjusted Net Income and Basic and Diluted Adjusted Net Income per Share in conjunction with the related GAAP measures.

Additionally, we have provided estimates regarding Consolidated Adjusted EBITDA for 2024. These projections account for estimates of revenue, operating margins and corporate and other costs. However, we cannot reconcile our projection of Consolidated Adjusted EBITDA to net income (loss), the most directly comparable GAAP measure, without unreasonable efforts because of the unpredictable or unknown nature of certain significant items excluded from Consolidated Adjusted EBITDA and the resulting difficulty in quantifying the amounts thereof that are necessary to estimate net income (loss). Specifically, we are unable to estimate for the future impact of certain items, including income tax (expense) benefit, stock-based compensation expense, fair value changes and the accounting for the issuance of the Series A-2 Preferred Stock. We expect the variability of these items could have a significant impact on our reported GAAP financial results.

In this release we also reference our organic growth. We define organic growth as the change in revenues excluding revenues from i) our environmental emergency response business, ii) acquisitions for the first twelve months following the date of acquisition, and iii) businesses held for sale, disposed of or discontinued. Management uses organic growth as one of the means by which it assesses our results of operations. Organic growth is not, however, a measure of revenue growth calculated in accordance with U.S. generally accepted accounting principles, or GAAP, and should be considered in conjunction with revenue growth calculated in accordance with GAAP. We have grown organically over the long term and expect to continue to do so.

In a given reporting period, when we refer to revenue changes driven by acquisitions, we are referring to the revenue contribution from any acquisition from its closing date through the first 12 months of that acquisition, at which point any subsequent contribution therefrom would be organic.


                                                                  
       
             Montrose Environmental Group, Inc.


                                                                
       
       Reconciliation of Net Loss to Adjusted Net Income


                                                                        
              (In thousands)


                                                                          
              (Unaudited)




                                                                                                                 Three Months Ended                         Nine Months Ended
                                                                                                        September 30,                             September 30,


                                                                                                        2024                         2023                 2024                          2023



              Net loss                                                                   $
              (10,564)                $
         (7,525)  $
              (34,091)            $
             (29,418)



              Amortization of intangible assets (1)                                                    10,055                          7,922                 24,621                          22,512



              Stock-based compensation (2)                                                             11,763                         11,484                 34,866                          35,609



              Acquisition costs (3)                                                                     2,764                          1,499                  6,371                           4,970



              Fair value changes in financial instruments (4)                                           3,946                            806                  4,851                           1,814



              Expenses related to financing transactions (5)                                               41                              3                    280                               7



              Fair value changes in business acquisition                                                  143                            459                    385                             414
    contingencies (6)



              Discontinued Specialty Lab (7)                                                               96                          1,302                    692                           5,321



              Other (gains) losses and expenses (8)                                                     1,378                            (1)                 1,886                             215



              Tax effect of adjustments (9)                                                             (565)                         (213)               (1,286)                          (514)



              Adjusted Net Income                                                          $
              19,057                  $
         15,736     $
              38,575               $
             40,930



              Series A-2 Preferred Stock dividends                                                    (2,750)                       (4,100)               (8,314)                       (12,300)



              Adjusted Net Income attributable to stockholders                             $
              16,307                  $
         11,636     $
              30,261               $
             28,630





              Net Loss per share attributable to stockholders                              $
              (0.39)                 $
         (0.39)    $
              (1.30)              $
             (1.39)



              Basic Adjusted Net Income per share (10)                                       $
              0.48                    $
         0.39       $
              0.93                 $
             0.95



              Diluted Adjusted Net Income per share (11)                                     $
              0.41                    $
         0.31       $
              0.80                 $
             0.78





              Weighted average common shares outstanding                                               34,242                         30,143                 32,647                          30,016



              Fully diluted shares                                                                     40,006                         36,952                 37,892                          36,640


     ___________________________________



     (1)                                 
     Represents amortization of intangible assets.



     (2)                                   Represents non-cash stock-based compensation expenses related to (i) option awards issued to employees, (ii) restricted stock grants issued to directors and selected employees, (iii) and stock appreciation rights grants issued
                                              to selected employees.



     (3)                                 
     Includes financial and tax diligence, consulting, legal, valuation, accounting and travel costs and acquisition-related incentives related to our acquisition activity.



     (4)                                 
     Amounts relate to the change in fair value of the interest rate swap instruments and the embedded derivative attached to the Series A-2 Preferred Stock.



     (5)                                 
     Amounts represent non-capitalizable expenses associated with refinancing and amending our debt facilities.



     (6)                                   Amounts reflect the difference between the expected settlement value of acquisition related earn-out payments at the time of the closing of acquisitions and the expected (or actual) value of earn-outs at the end of the relevant
                                              period.



     (7)                                 
     Amounts consist of operating losses before depreciation related to the Discontinued Specialty Lab.



     (8)                                 
     Amount in 2024 consists of costs associated with a lease abandonment. Amount in 2023 consists of costs associated with an aviation loss.



     (9)                                   The Company applied the estimated effective tax rate on portions of the adjustments related to our significant foreign entities, and determined the US portion of the adjustments do not have any tax impact since we are in a full
                                              deferred tax asset valuation allowance as of September 30, 2024.



     (10)                                
     Represents Adjusted Net Income attributable to stockholders divided by the weighted average number of shares of common stock outstanding.



     (11)                                
     Represents Adjusted Net Income attributable to stockholders divided by fully diluted number of shares of common stock.


                                                                      
     
                Montrose Environmental Group, Inc.


                                                                   
     
       Reconciliation of Net Loss to Consolidated Adjusted EBITDA


                                                                             
              (In thousands)


                                                                               
              (Unaudited)




                                                                                                                                 Three Months Ended                       Nine Months Ended
                                                                                                                        September 30,                            September 30,


                                                                                                                        2024                        2023                2024                      2023



     Net loss                                                                                            $
              (10,564)                $
        (7,525)  $
             (34,091)            $
         (29,418)



     Interest expense                                                                                                   4,137                         2,089                11,420                       5,507



     Income tax expense (benefit)                                                                                       1,368                         1,324                 4,480                       2,842



     Depreciation and amortization                                                                                     13,240                        11,863                37,408                      33,816



     EBITDA                                                                                                 $
              8,181                   $
        7,751    $
              19,217             $
           12,747



     Stock-based compensation (1)                                                                                      11,763                        11,484                34,866                      35,609



     Acquisition costs (2)                                                                                              2,764                         1,499                 6,371                       4,970



     Fair value changes in financial instruments (3)                                                                    3,946                           806                 4,851                       1,814



     Expenses related to financing transactions (4)                                                                        41                             3                   280                           7



     Fair value changes in business acquisition contingencies (5)                                                         143                           459                   385                         414



     Discontinued Specialty Lab (6)                                                                                        96                         1,302                   692                       5,321



     Other (gains) losses and expenses (7)                                                                              1,378                           (1)                1,886                         215



     Consolidated Adjusted EBITDA                                                                          $
              28,312                  $
        23,303    $
              68,548             $
           61,097


     __________________________________



     (1)                                  Represents non-cash stock-based compensation expenses related to (i) option awards issued to employees, (ii) restricted stock grants issued to directors and selected employees, (iii) and stock
                                             appreciation rights grants issued to selected employees.



     (2)                                
     Includes financial and tax diligence, consulting, legal, valuation, accounting and travel costs and acquisition-related incentives related to our acquisition activity.



     (3)                                
     Amounts relate to the change in fair value of the interest rate swap instruments and the embedded derivative attached to the Series A-2 Preferred Stock.



     (4)                                
     Amounts represent non-capitalizable expenses associated with refinancing and amending our debt facilities.



     (5)                                  Reflects the difference between the expected settlement value of acquisition related earn-out payments at the time of the closing of acquisitions and the expected (or actual) value of earn-outs
                                             at the end of the relevant period.



     (6)                                
     Amounts consist of operating losses before depreciation related to the Discontinued Specialty Lab.



     (7)                                
     Amount in 2024 consists of costs associated with a lease abandonment. Amount in 2023 consist of costs associated with an aviation loss.

View original content to download multimedia:https://www.prnewswire.com/news-releases/montrose-environmental-group-reports-record-third-quarter-and-first-nine-months-2024-results-reaffirms-guidance-and-updates-strategic-capital-allocation-priorities-302297934.html

SOURCE Montrose Environmental Group, Inc.